Famotidine renal dose — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Renal function-based dose review
This scenario assesses Famotidine renal dose in a UK pharmacy practice context. Famotidine is renally cleared and dose reduction may be needed in significant renal impairment. The best answer is Renal function-based dose review because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: BNF